TLR5 and neoplasm: Such applications with proof of concept for TLR5 agonist therapeutic efficacy in preclinical studies include anticancer immunotherapy and prevention of metastasis10,25–28 and protection of normal (non-tumor) tissues from the toxicity of anticancer radio/chemotherapy6,14 and other types of stress and inflammatory syndromes4,7,12.